Gastric Cancer Drugs Market:
WiseGuyReports.com adds “Global Gastric Cancer Drugs Market Size, Status and Forecast 2020-2026” reports to its database.
Executive Summary
Global Gastric Cancer Drugs Market is valued approximately USD 3.0 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 15.5% over the forecast period 2020-2026. Gastric cancer, also known as stomach cancer, which is characterized by an intensification of cancerous cells within the lining of the stomach. This type of cancer is usually complex to identify because in most people it normally does not show symptoms at the earlier stages. While, gastric cancer is quite rare as compared to other forms of cancer. There are some other factors of gastric cancer that include certain diseases and conditions such as lymphoma, tumors in other parts of the digestive system, stomach polyps and many more. For these reasons, several chemotherapy drugs are used to treat gastric cancer, including: 5-FU (fluorouracil), frequently given along with leucovorin (folinic acid), Capecitabine (Xeloda), Carboplatin, and many more. High incidences of gastric cancer among people owing to unhealthy diet, increasing number of obesity cases and growing elderly population are the few factors responsible for high CAGR of the market over the forecast period. For instance, the National Cancer Institute (NCI) estimated that around 28,000 new cases of stomach cancer in 2017. Also, NCI estimates that stomach cancer is about 1.7 percent of new cancer cases in the United States. Similarly, as per the GLOBOCAN 2018, the number of prevalence cases of stomach cancer in Asia was around 769,728 and is projected to grow to almost 947,186 by 2025. Although gastric cancer therapies can increase the chances of survival for patients living with gastric cancer. This, in turn, is expected to accelerate the demand of Gastric Cancer Drugs around the world. Amidst the COVID-19 outbreak across the world, the pharma industry is more concerned on the development of COVID-19 vaccine, thus, R&D efforts for gastric cancer drugs is substantially decline. Though, the demand for gastric cancer drugs is not affecting, and it is high as much as before the COVID-19 crisis. Therefore, the market will boost at significant rate in the upcoming years. However, high cost of cancer therapy and stringent regulations and policies for approval of the drugs are some other factors limiting the market growth over the forecast period of 2020-2026.
Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/5320645-global-gastric-cancer-drugs-market-size-study-with
The regional analysis of global Gastric Cancer Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia-Pacific is the leading/significant region across the world in terms of market share owing to rising number of gastric cancer cases, introduction of novel therapies for metastatic gastric cancer, and the presence of larger consumer base seeking treatment, particularly in China, India and Japan. Whereas, North America is anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to growing R&D efforts by pharmaceuticals for gastric cancer drugs and supportive government policies in the region.
Major market player included in this report are:
AMGEN
AROG Pharmaceuticals
Ipsen Biopharmaceuticals
Array Biopharma
Taiho Oncology
AstraZeneca
ARIAD Pharmaceuticals
Eli Lilly and Company
Galena Biopharma
ASLAN Pharmaceuticals
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Route of Administration:
Oral
Parenteral
By Lines of Chemotherapy:
First-line Chemotherapy
Second-line Chemotherapy
By Molecule Type:
Small Molecule
Biologics
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026
Target Audience of the Global Gastric Cancer Drugs Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Continuous…
For further information on this report, visit – https://www.wiseguyreports.com/reports/5320645-global-gastric-cancer-drugs-market-size-study-with
NOTE : Our team is studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
We conduct an accurate and reliable COVID Test.
Our qualified phlebotomists trained for safe and hygienic sample collecting during Test for COVID 19.
We are the most trustworthy lab for COVID 19 testing in India.
Get your COVID-19 Test done with Metropolis Healthcare.
Polysilicon Market:WiseGuyReports.com adds “Global Polysilicon Market Size, Status and Forecast 2020-2025” reports to its database.Executive SummaryThe Global Polysilicon Market valued at USD 7426 million in the year 2019 has been witnessing unprecedented growth.
Massive investments in expansion of solar capacity across the globe is a key driving factor for the growth of the Polysilicon market.
Governments of developing and developed countries and industrial sectors are emphasizing on the expansion of renewable energy sources, in which solar energy appears to show high potential.
Thus, policy makers, regulatory bodies and industrial sectors are investing enormously in the solar energy sector.
This is generating remarkable demand for solar panels across the globe.
The growth of the Polysilicon industry will however be slowed down because of the COVID-19 pandemic, which has completely halted all industries including manufacturing and logistics.Among the Application segment in the Polysilicon market (Solar Photovoltaic and Semiconductors), Solar Photovoltaic has been gaining popularity among other segments and is expected to keep major market share in the forecast period because of the adoption of energy sources that are sustainable.
Get all the updates about Covid-19 in UAE on Call Doctor UAE.
During the Covid-19 pandemic, we are providing premium home healthcare throughout Dubai & Abu Dhabi.
Bangladesh has Taken the Decision to Postpone the Upcoming Sri Lanka tour to Bangladesh Because of the COVID-19 Pandemic.
For More Details Visit Stumpsandbails.com
Market Research Future Published a Half-Cooked Research Report on Global Ink Resins Market Research Report - Global Forecast Till 2025 Global Ink Resins Market – SegmentationsThe Covid-19 Ink Resins Market Analysis has been segmented into four main dynamics to widen the scope of understanding,By Type: Modified Resin, Cellulose, Acrylic, Polyamide, Hydrocarbon, Polyurethane, and others.By Printing Process: Flexographic, Lithographic, Gravure, Digital, Letterpress, and others.By Application: Printing & Publication, Corrugated Boards, Flexible Packaging, and others.By Regions: Americas, Europe, Asia-Pacific, Middle East & Africa, and Rest-of-the-World.Global Ink Resins Market - Competitive LandscapeHighly competitive, the Ink Resins Market appears to be fragmented due to the presence of several large and small-scale players.
For business expansion, they acquire small yet promising companies in the emerging markets, focusing on optimized situational awareness for customers.
Rising strategic initiatives are changing the market structure by increasing the profit of the acquiring company and reducing market competition significantly.Major Players:Players Leading the Global Ink Resins Market include Arakawa Chemical Industries, Ltd (Japan), BASF SE (Germany), DowDuPont Inc (US), Royal DSM NV (Netherlands), Hydrite Chemical (US), Evonik Industries AG (Germany), Lawter (US), Indulor Chemie GmbH (Germany), Arizona Chemical Company, LLC (US), IGM Resins, Inc. (The Netherlands), US-Polymers-Accurez LLC (US), and Kraton Corporation (US), among others.Get Free Sample @ https://www.marketresearchfuture.com/sample_request/5093Industry/Innovation/Related News:November 09, 2019 —- Ingevity (the US), a specialty chemicals and materials manufacturer & supplier, launched its new environmentally friendly ink resin product line - AltaPrint.
Now available globally, The AltaPrint family of products offers customers a more eco-friendly solution without sacrificing gloss and film hardness performance characteristics.
The largest market share attributes to the growing demand from the packaging industry and expanding production capacities in the region.
Besides, factors such as the rising trend of on-the-go packaged food items & online shopping and the burgeoning eCommerce market in the region drive the market growth substantially.The presence of dynamically emerging economies in the region such as India, Japan, China, Singapore, and South Korea impacts the regional market growth positively.
